Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation.

S. Rich*, V. V. McLaughlin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Although lung transplantation is considered a definitive treatment of patients with advanced pulmonary vascular disease and pulmonary hypertension, advances in the success of the medical management of patients with pulmonary hypertension make it less clear as to when to refer a patient for transplantation. Coumadin anticoagulation is associated with improved survival in all patients, and calcium channel blockers therapy with improved survival in very select patients. Chronic prostacyclin represents a newer therapy that seems to have a dramatic impact on patients' functional class and survival. As improvements continue in the medical management in pulmonary hypertension, and in survival of patients undergoing lung transplantation, the guidelines for patient selection should be constantly evolving.

Original languageEnglish (US)
Pages (from-to)135-138
Number of pages4
JournalSeminars in thoracic and cardiovascular surgery
Volume10
Issue number2
DOIs
StatePublished - Apr 1998

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation.'. Together they form a unique fingerprint.

Cite this